In 2023, Fosun Pharma conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2023, Fosun Pharma generated a total of 56,029 metric tonnes of waste.
Of this amount, 67.99% of Fosun Pharma's total waste generated was recovered through methods such as recycling, reuse, or composting, while 32.01% was disposed of through landfilling, incineration, or combustion.
In 2023, Fosun Pharma reported a total waste generation of 56,029 metric tonnes, of which 67.99% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Fosun Pharma is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.
Since 2018, Fosun Pharma's total waste generation decreased by 34.7%, including a further 18.97% drop in 2023, highlighting a consistent and deliberate reduction in waste production over time.
In 2023, Fosun Pharma generated a total of 56,029 metric tonnes of waste.
Of this amount, 17.17% of Fosun Pharma's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 82.83% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2018, Fosun Pharma's total waste generation decreased by 34.7%, with an additional 18.97% decline in 2023, suggesting a consistent and deliberate effort to minimize waste generation at the source.
Over the same period, the share of hazardous waste in Fosun Pharma's total output increased by 448.94%, including a further 56.84% rise in 2023, suggesting a troubling upward shift toward more environmentally harmful waste streams that could raise compliance costs and environmental risks.
Overall, Fosun Pharma's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.
In 2023, Fosun Pharma reported that 9,618 metric tonnes of its total waste output were classified as hazardous. This represents 17.17% of its overall waste generation.
The company treated this hazardous waste using a combination of methods. Approximately 21.84% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.